Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

BioQuest Corp. BQST OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
10/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

BioQuest Corp. (BQST) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.47. It has a SharesGrow Score of 9/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $144,376, +0%/yr average growth. Net income is $781,400 (loss), growing at -211667.3%/yr. Net profit margin is -541.2% (negative). Gross margin is 29% (+0 pp trend).

Balance sheet: total debt is $388,102 against $201,718 equity (Debt-to-Equity (D/E) ratio 1.92, leveraged). Current ratio is 0.12 (tight liquidity). Debt-to-assets is 34.9%. Total assets: $1M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 25/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

BQST SharesGrow Score Overview

17/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 25/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BQST

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
BQST: +0%/yr revenue is, -211667.3%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
25/100
BQST: Gross margin is 29% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 25/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
BQST: Net profit margin is -541.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.4712-1.05
Volume12
Avg Volume (30D)5
Market Cap$5.41M
Beta (1Y)9.57
Share Statistics
EPS (TTM)-0.07
Shares Outstanding$11.67M
IPO Date2014-02-27
Employees4
CEOTrent T. Daniel
Financial Highlights & Ratios
Revenue (TTM)$144.38K
Gross Profit$41.92K
EBITDA$-781.4K
Net Income$-781.4K
Operating Income$-828.78K
Total Cash$2.08K
Total Debt$388.1K
Net Debt$386.02K
Total Assets$1.11M
Price / Earnings (P/E)-7
Price / Sales (P/S)37.48
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS09076H1023

Price Chart

Track all markets on TradingView
BQST
BioQuest Corp. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.47 52WK RANGE 1.05

People Also View

DNPUF
DNPUF
Sumitomo Pharma Co., Ltd.
$11.11
+0.00%
 HYPMY
HYPMY
Hypera S.A.
$4.67
-0.97%
 IZQVF
IZQVF
Indivior PLC
$20.97
+0.00%
 GNMLF
GNMLF
Genomma Lab Internacional, S.A.B. de C.V.
$1.08
+0.00%
 CPIX
CPIX
Cumberland Pharmaceuticals Inc.
$3.20
+0.63%
 ETST
ETST
Earth Science Tech, Inc.
$0.13
+6.50%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 PHCG
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
+4.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message